SC 13G/A | 2009-02-13 | Flynn James E | Cyclacel Pharmaceuticals, Inc. | 178,464 | 0.9% | EDGAR |
SC 13G/A | 2009-02-12 | FEDERATED INVESTORS INC /PA/ | Cyclacel Pharmaceuticals, Inc. | 1,450,126 | 6.7% | EDGAR |
SC 13G/A | 2009-01-09 | FEDERATED INVESTORS INC /PA/ | Cyclacel Pharmaceuticals, Inc. | 1,416,466 | 6.6% | EDGAR |
SC 13G/A | 2008-08-11 | FEDERATED INVESTORS INC /PA/ | Cyclacel Pharmaceuticals, Inc. | 2,853,976 | 13.2% | EDGAR |
SC 13G/A | 2008-03-14 | Flynn James E | Cyclacel Pharmaceuticals, Inc. | 935,526 | 4.5% | EDGAR |
SC 13G/A | 2008-02-14 | MORGAN STANLEY | Cyclacel Pharmaceuticals, Inc. | 3,075,524 | 15.1% | EDGAR |
SC 13G/A | 2008-02-14 | Visium Asset Management, LP | Cyclacel Pharmaceuticals, Inc. | 654,299 | 3.2% | EDGAR |
SC 13G/A | 2008-02-14 | Flynn James E | Cyclacel Pharmaceuticals, Inc. | 578,934 | 2.8% | EDGAR |
SC 13G/A | 2008-02-13 | Invesco Ltd. | Cyclacel Pharmaceuticals, Inc. | 996,128 | 4.9% | EDGAR |
SC 13G/A | 2008-02-13 | FEDERATED INVESTORS INC /PA/ | Cyclacel Pharmaceuticals, Inc. | 3,250,000 | 18.8% | EDGAR |
SC 13G | 2007-07-17 | Visium Balanced Fund LP | Cyclacel Pharmaceuticals, Inc. | 319,855 | 1.6% | EDGAR |
SC 13G | 2007-02-14 | AMVESCAP PLC/LONDON/ | Cyclacel Pharmaceuticals, Inc. | 931,313 | 5.8% | EDGAR |
SC 13G/A | 2007-02-13 | Flynn James E | Cyclacel Pharmaceuticals, Inc. | 563,800 | 3.4% | EDGAR |
SC 13G/A | 2007-02-13 | FEDERATED INVESTORS INC /PA/ | Cyclacel Pharmaceuticals, Inc. | 3,000,000 | 17.6% | EDGAR |
SC 13G | 2007-01-10 | MORGAN STANLEY | Cyclacel Pharmaceuticals, Inc. | 1,753,144 | 10.9% | EDGAR |
SC 13G/A | 2006-12-08 | ALTA PARTNERS | Cyclacel Pharmaceuticals, Inc. | 425,529 | 2.6% | EDGAR |
SC 13G | 2006-05-10 | FEDERATED INVESTORS INC /PA/ | Cyclacel Pharmaceuticals, Inc. | 3,000,000 | 17.7% | EDGAR |
SC 13G | 2006-05-09 | Flynn James E | Cyclacel Pharmaceuticals, Inc. | 563,800 | 3.5% | EDGAR |
SC 13D/A | 2006-04-13 | ARCH VENTURE FUND V LP | Cyclacel Pharmaceuticals, Inc. | - | - | EDGAR |
SC 13G | 2006-04-07 | INVESCO PRIVATE CAPITAL INC | Cyclacel Pharmaceuticals, Inc. | 931,313 | - | EDGAR |